Titre : Arénavirus de l'Ancien Monde

Arénavirus de l'Ancien Monde : Questions médicales fréquentes

Termes MeSH sélectionnés :

Quantitative Structure-Activity Relationship
{ "@context": "https://schema.org", "@graph": [ { "@type": "MedicalWebPage", "name": "Arénavirus de l'Ancien Monde : Questions médicales les plus fréquentes", "headline": "Arénavirus de l'Ancien Monde : Comprendre les symptômes, diagnostics et traitements", "description": "Guide complet et accessible sur les Arénavirus de l'Ancien Monde : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.", "datePublished": "2024-06-19", "dateModified": "2025-03-16", "inLanguage": "fr", "medicalAudience": [ { "@type": "MedicalAudience", "name": "Grand public", "audienceType": "Patient", "healthCondition": { "@type": "MedicalCondition", "name": "Arénavirus de l'Ancien Monde" }, "suggestedMinAge": 18, "suggestedGender": "unisex" }, { "@type": "MedicalAudience", "name": "Médecins", "audienceType": "Physician", "geographicArea": { "@type": "AdministrativeArea", "name": "France" } }, { "@type": "MedicalAudience", "name": "Chercheurs", "audienceType": "Researcher", "geographicArea": { "@type": "AdministrativeArea", "name": "International" } } ], "reviewedBy": { "@type": "Person", "name": "Dr Olivier Menir", "jobTitle": "Expert en Médecine", "description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale", "url": "/static/pages/docteur-olivier-menir.html", "alumniOf": { "@type": "EducationalOrganization", "name": "Université Paris Descartes" } }, "isPartOf": { "@type": "MedicalWebPage", "name": "Arenavirus", "url": "https://questionsmedicales.fr/mesh/D018050", "about": { "@type": "MedicalCondition", "name": "Arenavirus", "code": { "@type": "MedicalCode", "code": "D018050", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "B04.820.480.500.070" } } }, "hasPart": [ { "@type": "MedicalWebPage", "name": "Virus de Lassa", "alternateName": "Lassa virus", "url": "https://questionsmedicales.fr/mesh/D007836", "about": { "@type": "MedicalCondition", "name": "Virus de Lassa", "code": { "@type": "MedicalCode", "code": "D007836", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "B04.820.480.500.070.100.500" } } }, { "@type": "MedicalWebPage", "name": "Virus Lujo", "alternateName": "Lujo virus", "url": "https://questionsmedicales.fr/mesh/D063927", "about": { "@type": "MedicalCondition", "name": "Virus Lujo", "code": { "@type": "MedicalCode", "code": "D063927", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "B04.820.480.500.070.100.525" } } }, { "@type": "MedicalWebPage", "name": "Virus de la chorioméningite lymphocytaire", "alternateName": "Lymphocytic choriomeningitis virus", "url": "https://questionsmedicales.fr/mesh/D008217", "about": { "@type": "MedicalCondition", "name": "Virus de la chorioméningite lymphocytaire", "code": { "@type": "MedicalCode", "code": "D008217", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "B04.820.480.500.070.100.550" } } } ], "about": { "@type": "MedicalCondition", "name": "Arénavirus de l'Ancien Monde", "alternateName": "Arenaviruses, Old World", "code": { "@type": "MedicalCode", "code": "D018049", "codingSystem": "MeSH" } }, "author": [ { "@type": "Person", "name": "Slobodan Paessler", "url": "https://questionsmedicales.fr/author/Slobodan%20Paessler", "affiliation": { "@type": "Organization", "name": "Department of Pathology, Galveston National Laboratory and Institute for Human Infections and Immunity, University of Texas Medical Branch, Galveston, Texas, USA." } }, { "@type": "Person", "name": "Susan R Ross", "url": "https://questionsmedicales.fr/author/Susan%20R%20Ross", "affiliation": { "@type": "Organization", "name": "Department of Microbiology and Immunology, University of Illinois College of Medicine, Chicago, IL 60612 srross@uic.edu." } }, { "@type": "Person", "name": "Mathieu Mateo", "url": "https://questionsmedicales.fr/author/Mathieu%20Mateo", "affiliation": { "@type": "Organization", "name": "Unité de Biologie des Infections Virales Emergentes, Institut Pasteur, Lyon, France." } }, { "@type": "Person", "name": "Sylvain Baize", "url": "https://questionsmedicales.fr/author/Sylvain%20Baize", "affiliation": { "@type": "Organization", "name": "Unité de Biologie des Infections Virales Emergentes, Institut Pasteur, Lyon, France. sylvain.baize@pasteur.fr." } }, { "@type": "Person", "name": "Junki Maruyama", "url": "https://questionsmedicales.fr/author/Junki%20Maruyama", "affiliation": { "@type": "Organization", "name": "Department of Pathology, Galveston National Laboratory and Institute for Human Infections and Immunity, University of Texas Medical Branch, Galveston, Texas, USA." } } ], "citation": [ { "@type": "ScholarlyArticle", "name": "Design, Synthesis, Antibacterial Evaluation, Three-Dimensional Quantitative Structure-Activity Relationship, and Mechanism of Novel Quinazolinone Derivatives.", "datePublished": "2023-02-21", "url": "https://questionsmedicales.fr/article/36807581", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1021/acs.jafc.2c07264" } }, { "@type": "ScholarlyArticle", "name": "Automated machine learning approach for developing a quantitative structure-activity relationship model for cardiac steroid inhibition of Na", "datePublished": "2023-06-24", "url": "https://questionsmedicales.fr/article/37354314", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1007/s43440-023-00508-x" } }, { "@type": "ScholarlyArticle", "name": "Multivariate image analysis applied to quantitative structure-activity relationships and docking studies of recent hydroxyphenylpyruvate deoxygenase inhibitors.", "datePublished": "2023-04-18", "url": "https://questionsmedicales.fr/article/37021557", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1002/jsfa.12608" } }, { "@type": "ScholarlyArticle", "name": "Artificial Intelligence-Based Quantitative Structure-Property Relationship Model for Predicting Human Intestinal Absorption of Compounds with Serotonergic Activity.", "datePublished": "2023-04-18", "url": "https://questionsmedicales.fr/article/37070956", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1021/acs.molpharmaceut.2c01117" } }, { "@type": "ScholarlyArticle", "name": "Development of a quantitative structure-activity relationship model for predicting quantum yield of hydroxyl radical generation from organic compounds.", "datePublished": "2023-01-25", "url": "https://questionsmedicales.fr/article/36504232", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1039/d2em00396a" } } ], "breadcrumb": { "@type": "BreadcrumbList", "itemListElement": [ { "@type": "ListItem", "position": 1, "name": "questionsmedicales.fr", "item": "https://questionsmedicales.fr" }, { "@type": "ListItem", "position": 2, "name": "Virus", "item": "https://questionsmedicales.fr/mesh/D014780" }, { "@type": "ListItem", "position": 3, "name": "Virus à ARN", "item": "https://questionsmedicales.fr/mesh/D012328" }, { "@type": "ListItem", "position": 4, "name": "Virus à ARN de polarité négative", "item": "https://questionsmedicales.fr/mesh/D000086103" }, { "@type": "ListItem", "position": 5, "name": "Arenaviridae", "item": "https://questionsmedicales.fr/mesh/D001116" }, { "@type": "ListItem", "position": 6, "name": "Arenavirus", "item": "https://questionsmedicales.fr/mesh/D018050" }, { "@type": "ListItem", "position": 7, "name": "Arénavirus de l'Ancien Monde", "item": "https://questionsmedicales.fr/mesh/D018049" } ] } }, { "@type": "MedicalWebPage", "name": "Article complet : Arénavirus de l'Ancien Monde - Questions et réponses", "headline": "Questions et réponses médicales fréquentes sur Arénavirus de l'Ancien Monde", "description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.", "datePublished": "2025-05-14", "inLanguage": "fr", "hasPart": [ { "@type": "MedicalWebPage", "name": "Diagnostic", "headline": "Diagnostic sur Arénavirus de l'Ancien Monde", "description": "Comment diagnostiquer une infection par arénavirus ?\nQuels tests sont utilisés pour les arénavirus ?\nLes symptômes aident-ils au diagnostic ?\nQuand faire un test pour arénavirus ?\nLes tests sont-ils fiables pour tous les arénavirus ?", "url": "https://questionsmedicales.fr/mesh/D018049?mesh_terms=Quantitative+Structure-Activity+Relationship&page=3#section-diagnostic" }, { "@type": "MedicalWebPage", "name": "Symptômes", "headline": "Symptômes sur Arénavirus de l'Ancien Monde", "description": "Quels sont les symptômes courants des arénavirus ?\nLes symptômes varient selon le virus ?\nY a-t-il des symptômes spécifiques aux arénavirus ?\nLes symptômes apparaissent-ils rapidement ?\nLes symptômes peuvent-ils être graves ?", "url": "https://questionsmedicales.fr/mesh/D018049?mesh_terms=Quantitative+Structure-Activity+Relationship&page=3#section-symptômes" }, { "@type": "MedicalWebPage", "name": "Prévention", "headline": "Prévention sur Arénavirus de l'Ancien Monde", "description": "Comment prévenir les infections par arénavirus ?\nLes vaccins existent-ils pour les arénavirus ?\nQuelles mesures d'hygiène sont recommandées ?\nLes voyages dans certaines zones sont-ils risqués ?\nLes rongeurs doivent-ils être contrôlés ?", "url": "https://questionsmedicales.fr/mesh/D018049?mesh_terms=Quantitative+Structure-Activity+Relationship&page=3#section-prévention" }, { "@type": "MedicalWebPage", "name": "Traitements", "headline": "Traitements sur Arénavirus de l'Ancien Monde", "description": "Quel est le traitement des infections par arénavirus ?\nLes antibiotiques sont-ils efficaces contre les arénavirus ?\nComment gérer les symptômes graves ?\nY a-t-il des antiviraux pour les arénavirus ?\nLe traitement préventif est-il possible ?", "url": "https://questionsmedicales.fr/mesh/D018049?mesh_terms=Quantitative+Structure-Activity+Relationship&page=3#section-traitements" }, { "@type": "MedicalWebPage", "name": "Complications", "headline": "Complications sur Arénavirus de l'Ancien Monde", "description": "Quelles complications peuvent survenir ?\nLes complications sont-elles fréquentes ?\nComment gérer les complications ?\nLes complications peuvent-elles être mortelles ?\nY a-t-il des séquelles après l'infection ?", "url": "https://questionsmedicales.fr/mesh/D018049?mesh_terms=Quantitative+Structure-Activity+Relationship&page=3#section-complications" }, { "@type": "MedicalWebPage", "name": "Facteurs de risque", "headline": "Facteurs de risque sur Arénavirus de l'Ancien Monde", "description": "Qui est à risque d'infection par arénavirus ?\nLes travailleurs de la santé sont-ils plus exposés ?\nLes voyageurs sont-ils à risque ?\nLes personnes immunodéprimées sont-elles plus vulnérables ?\nLes enfants sont-ils plus à risque ?", "url": "https://questionsmedicales.fr/mesh/D018049?mesh_terms=Quantitative+Structure-Activity+Relationship&page=3#section-facteurs de risque" } ] }, { "@type": "FAQPage", "mainEntity": [ { "@type": "Question", "name": "Comment diagnostiquer une infection par arénavirus ?", "position": 1, "acceptedAnswer": { "@type": "Answer", "text": "Le diagnostic repose sur des tests sérologiques et PCR pour détecter le virus." } }, { "@type": "Question", "name": "Quels tests sont utilisés pour les arénavirus ?", "position": 2, "acceptedAnswer": { "@type": "Answer", "text": "Les tests sérologiques, PCR et culture virale sont couramment utilisés." } }, { "@type": "Question", "name": "Les symptômes aident-ils au diagnostic ?", "position": 3, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les symptômes cliniques orientent le diagnostic, mais ne suffisent pas." } }, { "@type": "Question", "name": "Quand faire un test pour arénavirus ?", "position": 4, "acceptedAnswer": { "@type": "Answer", "text": "Un test doit être effectué si des symptômes de fièvre hémorragique apparaissent." } }, { "@type": "Question", "name": "Les tests sont-ils fiables pour tous les arénavirus ?", "position": 5, "acceptedAnswer": { "@type": "Answer", "text": "La fiabilité peut varier selon le type d'arénavirus et le test utilisé." } }, { "@type": "Question", "name": "Quels sont les symptômes courants des arénavirus ?", "position": 6, "acceptedAnswer": { "@type": "Answer", "text": "Les symptômes incluent fièvre, fatigue, douleurs musculaires et hémorragies." } }, { "@type": "Question", "name": "Les symptômes varient selon le virus ?", "position": 7, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les symptômes peuvent varier selon le type d'arénavirus infectant." } }, { "@type": "Question", "name": "Y a-t-il des symptômes spécifiques aux arénavirus ?", "position": 8, "acceptedAnswer": { "@type": "Answer", "text": "Des symptômes comme des saignements et des éruptions cutanées peuvent être spécifiques." } }, { "@type": "Question", "name": "Les symptômes apparaissent-ils rapidement ?", "position": 9, "acceptedAnswer": { "@type": "Answer", "text": "Les symptômes peuvent apparaître rapidement, généralement dans les 1 à 2 semaines." } }, { "@type": "Question", "name": "Les symptômes peuvent-ils être graves ?", "position": 10, "acceptedAnswer": { "@type": "Answer", "text": "Oui, certains cas peuvent évoluer vers des formes graves, nécessitant une attention médicale." } }, { "@type": "Question", "name": "Comment prévenir les infections par arénavirus ?", "position": 11, "acceptedAnswer": { "@type": "Answer", "text": "Éviter le contact avec les rongeurs et leurs excréments est essentiel pour la prévention." } }, { "@type": "Question", "name": "Les vaccins existent-ils pour les arénavirus ?", "position": 12, "acceptedAnswer": { "@type": "Answer", "text": "Actuellement, il n'existe pas de vaccins approuvés pour les arénavirus de l'Ancien Monde." } }, { "@type": "Question", "name": "Quelles mesures d'hygiène sont recommandées ?", "position": 13, "acceptedAnswer": { "@type": "Answer", "text": "Maintenir une bonne hygiène, comme le nettoyage régulier, aide à prévenir les infections." } }, { "@type": "Question", "name": "Les voyages dans certaines zones sont-ils risqués ?", "position": 14, "acceptedAnswer": { "@type": "Answer", "text": "Oui, voyager dans des zones endémiques augmente le risque d'infection par arénavirus." } }, { "@type": "Question", "name": "Les rongeurs doivent-ils être contrôlés ?", "position": 15, "acceptedAnswer": { "@type": "Answer", "text": "Oui, le contrôle des populations de rongeurs est crucial pour réduire le risque d'infection." } }, { "@type": "Question", "name": "Quel est le traitement des infections par arénavirus ?", "position": 16, "acceptedAnswer": { "@type": "Answer", "text": "Il n'existe pas de traitement antiviral spécifique ; le soutien symptomatique est essentiel." } }, { "@type": "Question", "name": "Les antibiotiques sont-ils efficaces contre les arénavirus ?", "position": 17, "acceptedAnswer": { "@type": "Answer", "text": "Non, les antibiotiques ne sont pas efficaces contre les infections virales comme celles-ci." } }, { "@type": "Question", "name": "Comment gérer les symptômes graves ?", "position": 18, "acceptedAnswer": { "@type": "Answer", "text": "Les symptômes graves nécessitent une hospitalisation et des soins intensifs." } }, { "@type": "Question", "name": "Y a-t-il des antiviraux pour les arénavirus ?", "position": 19, "acceptedAnswer": { "@type": "Answer", "text": "Actuellement, il n'existe pas d'antiviraux spécifiquement approuvés pour les arénavirus." } }, { "@type": "Question", "name": "Le traitement préventif est-il possible ?", "position": 20, "acceptedAnswer": { "@type": "Answer", "text": "Il n'existe pas de traitement préventif, mais la vaccination est en cours d'étude." } }, { "@type": "Question", "name": "Quelles complications peuvent survenir ?", "position": 21, "acceptedAnswer": { "@type": "Answer", "text": "Les complications incluent des hémorragies, des défaillances organiques et des infections secondaires." } }, { "@type": "Question", "name": "Les complications sont-elles fréquentes ?", "position": 22, "acceptedAnswer": { "@type": "Answer", "text": "Les complications graves sont rares mais peuvent survenir dans des cas sévères." } }, { "@type": "Question", "name": "Comment gérer les complications ?", "position": 23, "acceptedAnswer": { "@type": "Answer", "text": "La gestion des complications nécessite des soins médicaux intensifs et un suivi rigoureux." } }, { "@type": "Question", "name": "Les complications peuvent-elles être mortelles ?", "position": 24, "acceptedAnswer": { "@type": "Answer", "text": "Oui, certaines complications peuvent être mortelles, surtout sans traitement approprié." } }, { "@type": "Question", "name": "Y a-t-il des séquelles après l'infection ?", "position": 25, "acceptedAnswer": { "@type": "Answer", "text": "Des séquelles peuvent survenir, notamment des problèmes neurologiques ou respiratoires." } }, { "@type": "Question", "name": "Qui est à risque d'infection par arénavirus ?", "position": 26, "acceptedAnswer": { "@type": "Answer", "text": "Les personnes en contact avec des rongeurs ou vivant dans des zones endémiques sont à risque." } }, { "@type": "Question", "name": "Les travailleurs de la santé sont-ils plus exposés ?", "position": 27, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les travailleurs de la santé peuvent être exposés lors de soins à des patients infectés." } }, { "@type": "Question", "name": "Les voyageurs sont-ils à risque ?", "position": 28, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les voyageurs dans des régions endémiques courent un risque accru d'infection." } }, { "@type": "Question", "name": "Les personnes immunodéprimées sont-elles plus vulnérables ?", "position": 29, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les personnes immunodéprimées peuvent avoir un risque accru de complications graves." } }, { "@type": "Question", "name": "Les enfants sont-ils plus à risque ?", "position": 30, "acceptedAnswer": { "@type": "Answer", "text": "Les enfants peuvent être à risque, mais les adultes sont généralement plus touchés par les complications." } } ] } ] }

Sources (10000 au total)

Design, Synthesis, Antibacterial Evaluation, Three-Dimensional Quantitative Structure-Activity Relationship, and Mechanism of Novel Quinazolinone Derivatives.

Plant bacterial illnesses are common and cause dramatic damage to agricultural goods all over the world, yet there are few efficient bactericides to alleviate them at present. To discover novel antiba...

Automated machine learning approach for developing a quantitative structure-activity relationship model for cardiac steroid inhibition of Na

Quantitative structure-activity relationship (QSAR) modeling is a method of characterizing the relationship between chemical structures and biological activity. Automated machine learning enables comp... The chemical structures and inhibitory activities of 215 CS derivatives were obtained from the scientific literature. Predictive QSAR models were constructed using molecular descriptors, fingerprints,... The best predictive QSAR models were selected based on the LogLoss value. Using these models, the Matthews correlation coefficient, F1 score, and area under the curve of the test dataset were 0.6729, ... The automated machine learning-based QSAR method developed here should be applicable for the time-efficient construction of predictive models using only a small number of compounds....

Multivariate image analysis applied to quantitative structure-activity relationships and docking studies of recent hydroxyphenylpyruvate deoxygenase inhibitors.

Mesotrione is a triketone widely used as an inhibitor of the hydroxyphenylpyruvate deoxygenase (HPPD) enzyme. However, new agrochemicals should be developed continuously to tackle the problem of herbi... The MIA-QSAR models based on van der Waals radii (r... Multivariate image analysis descriptors corroborated by docking studies were capable of modeling the herbicidal activities of 68 triketones reliably. Due to the substituent effects at the triketone fr...

Artificial Intelligence-Based Quantitative Structure-Property Relationship Model for Predicting Human Intestinal Absorption of Compounds with Serotonergic Activity.

Oral medicines represent the largest pharmaceutical market area. To achieve a therapeutic effect, a drug must penetrate the intestinal walls, the main absorption site for orally delivered active pharm...

Development of a quantitative structure-activity relationship model for predicting quantum yield of hydroxyl radical generation from organic compounds.

Organic compounds are capable of generating hydroxyl radicals (˙OH) through their excited triplet states in natural water. It is of significance to reveal the underlying mechanism of the generation an...

In vitro and Quantitative and Structure Activity Relationship (QSAR) evaluation of the antifungal activity of terpenoid constituents of essential oils against Alternaria alternata and Fusarium oxysporum

Fungal genera Alternaria and Fusarium include human and plant pathogenic species. Several antifungals have been used for their control, but excessive use has contributed to resistance development in p... To evaluate in vitro and in silico the antifungal activities of terpenoids against Alternaria alternata and Fusarium oxysporum.... The minimum inhibitory concentration and minimum fungicidal concentration values of 27 constituents of essential oils used against Alternaria alternata and Fusarium oxysporum were evaluated in vitro. ... The evaluated compounds proved to be effective antifungals. Thymol was the most active with a minimum inhibitory concentration of 91.6 ± 28.8 μg/ml for A. alternata and F. oxysporum. Quantitative stru... Terpenoids exhibit relevant antifungal activities that should be incorporated into the study of medicinal chemistry. Inclusion of in silico assays in the in vitro evaluation is a valuable tool in the ...

Three-dimensional quantitative structural-activity relationship and molecular dynamics study of multivariate substituted 4-oxyquinazoline HDAC6 inhibitors.

3D-QSAR models were established by collecting 46 multivariate-substituted 4-oxyquinazoline HDAC6 inhibitors. The relationship of molecular structure and inhibitory activity was studied by comparative ...

Identification of Potent Small-Molecule PCSK9 Inhibitors Based on Quantitative Structure-Activity Relationship, Pharmacophore Modeling, and Molecular Docking Procedure.

The leading cause of atherosclerotic cardiovascular disease (ASCVD) is elevated low-density lipoprotein cholesterol (LDL-C). Proprotein convertase subtilisin/kexin type 9 (PCSK9) attaches to the domai...

An Empirical Quantitative Structure-Activity Relationship Equation Assists the Discovery of High-Affinity Phosphodiesterase 4D Inhibitors as Leads to PET Radioligands.

A positron emission tomography (PET) radioligand for imaging phosphodiesterase 4D (PDE4D) would benefit drug discovery and the investigation of neuropsychiatric disorders. The most promising radioliga...